These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Elimination or neutralization of endogenous high-molecular-weight FGF2 mitigates doxorubicin-induced cardiotoxicity. Koleini N; Santiago JJ; Nickel BE; Sequiera GL; Wang J; Fandrich RR; Jassal DS; Dhingra S; Kirshenbaum LA; Cattini PA; Kardami E Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H279-H288. PubMed ID: 30412444 [TBL] [Abstract][Full Text] [Related]
3. A Cardiac Mitochondrial FGFR1 Mediates the Antithetical Effects of FGF2 Isoforms on Permeability Transition. Srisakuldee W; Nickel BE; Fandrich RR; Zhang F; Pasumarthi KBS; Kardami E Cells; 2021 Oct; 10(10):. PubMed ID: 34685716 [TBL] [Abstract][Full Text] [Related]
4. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. Dell'Era P; Mohammadi M; Presta M Mol Biol Cell; 1999 Jan; 10(1):23-33. PubMed ID: 9880324 [TBL] [Abstract][Full Text] [Related]
5. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury. Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383 [TBL] [Abstract][Full Text] [Related]
6. High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected]. Jiang ZS; Wen GB; Tang ZH; Srisakuldee W; Fandrich RR; Kardami E Can J Physiol Pharmacol; 2009 Oct; 87(10):798-804. PubMed ID: 19898562 [TBL] [Abstract][Full Text] [Related]
7. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice. Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561 [TBL] [Abstract][Full Text] [Related]
8. Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo. Blanton RM; Takimoto E; Lane AM; Aronovitz M; Piotrowski R; Karas RH; Kass DA; Mendelsohn ME J Am Heart Assoc; 2012 Oct; 1(5):e003731. PubMed ID: 23316302 [TBL] [Abstract][Full Text] [Related]
9. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload. Zhou N; Ma B; Stoll S; Hays TT; Qiu H Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247 [TBL] [Abstract][Full Text] [Related]
10. FGF2 modulates cardiac remodeling in an isoform- and sex-specific manner. Nusayr E; Sadideen DT; Doetschman T Physiol Rep; 2013 Sep; 1(4):. PubMed ID: 24244869 [TBL] [Abstract][Full Text] [Related]
11. ANO1 relieves pressure overload-induced myocardial fibrosis in mice by inhibiting TGF-β/Smad3 signaling pathway. Kong JC; Miao WQ; Wang Y; Zhou SF Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8493-8501. PubMed ID: 32894555 [TBL] [Abstract][Full Text] [Related]
12. Ventricular TLR4 Levels Abrogate TLR2-Mediated Adverse Cardiac Remodeling upon Pressure Overload in Mice. Kessler EL; Wang JW; Kok B; Brans MA; Nederlof A; van Stuijvenberg L; Huang C; Vink A; Arslan F; Efimov IR; Lam CSP; Vos MA; de Kleijn DPV; Fontes MSC; van Veen TAB Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769252 [TBL] [Abstract][Full Text] [Related]
13. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response. Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634 [TBL] [Abstract][Full Text] [Related]
14. Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice. Matsushita N; Ishida N; Ibi M; Saito M; Sanbe A; Shimojo H; Suzuki S; Koepsell H; Takeishi Y; Morino Y; Taira E; Sawa Y; Hirose M Int Heart J; 2018 Sep; 59(5):1123-1133. PubMed ID: 30101852 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling. Suh J; Kim DH; Lee YH; Jang JH; Surh YJ Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854 [TBL] [Abstract][Full Text] [Related]
17. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart. Nawaito SA; Dingar D; Sahadevan P; Hussein B; Sahmi F; Shi Y; Gillis MA; Gaestel M; Tardif JC; Allen BG Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H46-H58. PubMed ID: 28432058 [TBL] [Abstract][Full Text] [Related]
18. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice. Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805 [TBL] [Abstract][Full Text] [Related]
19. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice. Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046 [TBL] [Abstract][Full Text] [Related]
20. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction. Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]